Tenet Bio-Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 05-12-2024
- Paid Up Capital ₹ 3.70 M
as on 05-12-2024
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 63.62%
(FY 2022)
- Profit 23098.77%
(FY 2022)
- Ebitda 6327.55%
(FY 2022)
- Net Worth 7.09%
(FY 2022)
- Total Assets -15.30%
(FY 2022)
About Tenet Bio-Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.70 M, as per Ministry of Corporate Affairs (MCA) records.
Hansraj Goyal and Neelam Goyal serve as directors at the Company.
- CIN/LLPIN
U24232RJ2005PTC021155
- Company No.
021155
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Aug 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- LocationJaipur, Rajasthan
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Tenet Bio-Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hansraj Goyal  | Director | 20-Jul-2006 | Current |
| Neelam Goyal | Director | 16-Dec-2008 | Current |
Financial Performance of Tenet Bio-Pharma.
Tenet Bio-Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 63.62% increase. The company also saw a substantial improvement in profitability, with a 23098.77% increase in profit. The company's net worth moved up by a moderate rise of 7.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tenet Bio-Pharma?
In 2021, Tenet Bio-Pharma had a promoter holding of 10.81% and a public holding of 89.19%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tenet Bio-Pharma?
Unlock and access historical data on people associated with Tenet Bio-Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tenet Bio-Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tenet Bio-Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
